腹筋条性普罗迪诺芬和普罗恩基法林之间的平衡偏移偏向可卡因避开地点的发展
bioRxiv : the preprint server for biology
|March 10, 2025
概括
可卡因引发负面情绪,可能会影响使用. 研究人员发现,条纹性迪诺芬水平与可卡因诱导的厌恶相关,这表明它在成脆弱性中发挥了作用.
科学领域:
- 神经科学是一个神经科学.
- 行为药理学行为药理学
- 分子生物学分子生物学
背景情况:
- 可卡因使用会导致负面情绪状态,如焦虑和恐慌.
- 条形体中的丁诺芬信号与可卡因戒断期间的负面情绪和压力诱导的寻找有关.
- 条件避开 (CPA) 是一种行为模型,用于研究药物诱导的情绪状态.
研究的目的:
- 用小鼠的微量调节来优化捕捉可卡因诱导的负面影响的参数.
- 调查条纹性阿片类,特别是恩基法林和迪诺芬在调解可卡因CPA中的作用.
- 探索丁诺芬和恩基法林的条状基因表达与可卡因诱导的厌恶之间的关系.
主要方法:
- 在野生型小鼠中使用微量调节程序来确定可卡因CPA.
- 测试了各种可卡因剂量,调节会话长度和设备类型,以优化CPA.
- 使用定量聚合酶链反应 (qPCR) 来量化基因表达的恩基法林 (Penk) 和基因 (Pdyn).
主要成果:
- 观察到可卡因CPA,尽管剂量和装置等参数影响了可变性和短暂性.
- 可卡因CPA得分分化,大致相同比例的小鼠表现出偏好或避免.
- 腹状条纹体中低Pdyn水平和低Pdyn:Penk比率与可卡因CPA相关.
- 具有较高相对Pdyn水平的小鼠对开发可卡因CPA具有更强的抵抗力.
结论:
- 条形状的迪诺芬在调解对可卡因的情感反应方面发挥着复杂的作用.
- 迪诺芬在急性可卡因中毒厌恶和戒断诱导的厌恶中可能具有相反的功能.
- 这项研究确定了一组对可卡因后立即厌恶状态敏感的受试者,这些状态与条纹性恐诺芬表达有关.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
420
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
420
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K


